Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 498-501, April 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sbarra, A. J.
Right arrow Articles by Rosenbaum, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sbarra, A. J.
Right arrow Articles by Rosenbaum, E.

The Inhibitory Nature of Lymphocytic Leukemic Serum on Microorganisms*

Anthony J. Sbarra, Eietsu Ouchi{dagger} and Ernest Rosenbaum{ddagger}

( Department of Pathology and Medical Research, St. Margaret's Hospital, and Department of Obstetrics and Gynecology, Tufts University Medical School, Boston, Mass.)

The sera of patients afflicted with either acute or chronic lymphocytic leukemia were found to significantly inhibit the respiratory activity of Bacillus subtilis to a much greater extent than any other sera tested. The inhibitor is destroyed by heating at 65° C. for 30 min., it can be absorbed out by heat-killed homologous organisms, and is nondialyzable. These data indicate that the factor is probably a protein. The inhibitor appears to cause bacteriostasis, since the addition of either yeast extract or trypticase soy will reverse the inhibitory effect brought about by the acute or chronic lymphocytic leukemic serum.

* This work was supported by research grants: P 311 from the American Cancer Society, CAO5307 from the National Cancer Institute, and G19531 from the National Science Foundation.

{dagger} Charlton Fellow, Department of Obstetrics and Gynecology, Tufts University School of Medicine.

{ddagger} Blood Research Laboratory, New England Center Hospital, Boston, Mass. Present address: 2233 Post Street, San Francisco, Calif.

Received 10/15/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.